95 related articles for article (PubMed ID: 18466687)
1. Mucus hypersecretion in the airway.
Wang K; Wen FQ; Xu D
Chin Med J (Engl); 2008 Apr; 121(7):649-52. PubMed ID: 18466687
[No Abstract] [Full Text] [Related]
2. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
Rogers DF
Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of human aquaporin-5 correlated with mucus overproduction in airways of chronic obstructive pulmonary disease.
Wang K; Feng YL; Wen FQ; Chen XR; Ou XM; Xu D; Yang J; Deng ZP
Acta Pharmacol Sin; 2007 Aug; 28(8):1166-74. PubMed ID: 17640479
[TBL] [Abstract][Full Text] [Related]
4. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
Lai H; Rogers DF
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
[TBL] [Abstract][Full Text] [Related]
5. [Potential therapy for mucus hypersecretion in chronic obstructive pulmonary disease].
Park JA; Adler KB
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2890-2. PubMed ID: 17288783
[No Abstract] [Full Text] [Related]
6. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma.
Singer M; Martin LD; Vargaftig BB; Park J; Gruber AD; Li Y; Adler KB
Nat Med; 2004 Feb; 10(2):193-6. PubMed ID: 14716307
[TBL] [Abstract][Full Text] [Related]
7. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
Restrepo RD
Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384
[TBL] [Abstract][Full Text] [Related]
8. Regulation of mucin genes in chronic inflammatory airway diseases.
Voynow JA; Gendler SJ; Rose MC
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):661-5. PubMed ID: 16456183
[TBL] [Abstract][Full Text] [Related]
9. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
10. Airway epithelium and mucus: intracellular signaling pathways for gene expression and secretion.
Adler KB; Li Y
Am J Respir Cell Mol Biol; 2001 Oct; 25(4):397-400. PubMed ID: 11694442
[No Abstract] [Full Text] [Related]
11. Simvastatin attenuates lipopolysaccharide-induced airway mucus hypersecretion in rats.
Ou XM; Wang BD; Wen FQ; Feng YL; Huang XY; Xiao J
Chin Med J (Engl); 2008 Sep; 121(17):1680-7. PubMed ID: 19024099
[TBL] [Abstract][Full Text] [Related]
12. LPS-stimulated MUC5AC production involves Rac1-dependent MMP-9 secretion and activation in NCI-H292 cells.
Binker MG; Binker-Cosen AA; Richards D; Oliver B; Cosen-Binker LI
Biochem Biophys Res Commun; 2009 Aug; 386(1):124-9. PubMed ID: 19501047
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism and management of airway hypersecretion in obstructive lung disease].
Tamaoki J
Nihon Rinsho; 1999 Sep; 57(9):2056-61. PubMed ID: 10497406
[TBL] [Abstract][Full Text] [Related]
14. [Effects of selective phosphodiesterase 4 inhibitor on expression of aquaporin 5 in airway mucus hypersecretion model of rats].
Jia WH; Yang P; Li J; Tian ZL
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):619-22. PubMed ID: 23663346
[TBL] [Abstract][Full Text] [Related]
15. [AIRWAY MUCUS HYPERSECRETION AS A THERAPEUTIC TARGET OF ASTHMA].
Tamaoki J
Arerugi; 2017; 66(10):1218-1223. PubMed ID: 29249754
[No Abstract] [Full Text] [Related]
16. Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling.
Huang MT; Dai YS; Chou YB; Juan YH; Wang CC; Chiang BL
J Immunol; 2009 Oct; 183(7):4745-54. PubMed ID: 19752226
[TBL] [Abstract][Full Text] [Related]
17. Mucus-controlling agents: past and present.
King M; Rubin BK
Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882
[TBL] [Abstract][Full Text] [Related]
18. The physiology of mucus and sputum production in the respiratory system.
Richardson M
Nurs Times; 2003 Jun 10-16; 99(23):63-4. PubMed ID: 12838653
[TBL] [Abstract][Full Text] [Related]
19. Conventional chest physical therapy for obstructive lung disease.
van der Schans CP
Respir Care; 2007 Sep; 52(9):1198-206; discussion 1206-9. PubMed ID: 17716386
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
